NCI Joins 6 partners to sign G7 Cancer MOU to Strengthen Coordination to Accelerate Progress Against Cancer Worldwide
Claudia Mayer, Catherine Elliott, Hitoshi Nakagama, Thierry Breton, Dorothy Keefe, Satish Gopal, Fei-Fei Liu
As part of the ten-year cancer control strategy, G7 Cancer officially launched on May 9. Bringing together the organizations at the forefront of the fight against cancer, this group aims to strengthen cooperation between partners to accelerate the fight against the disease, and in particular to address the most complex challenges. At the first meeting, which was held on May 9, at the National Cancer Institute (Paris, France), the organizations’ representatives signed a Memorandum of Understanding (MOU) to set the cooperation framework. They also defined priority actions and appointed the presidency for the next two years. During this first meeting, each organization had the opportunity on sharing priority topics and actions. The presidency, as well as the secretariat of the group, have been entrusted to the French National Cancer Institute for the next 2 years.
The priorities for the G7 Cancer for the next years are:
- International data strategy, focused on pediatric cancers as a model
- Poor prognosis cancers (pancreatic/esophagus/stomach and liver cancers)
- Cancer outcome inequities
- Prevention (precancers, screening programs, multi-cancer early detection)
In order to act on these priorities, the following actions have been proposed:
- International conference on data strategy for pediatric cancers
- International Dialogue on pancreatic, liver, esophagus, and stomach cancers
- Working group on cancer outcome inequities
- Working group on prevention and precancer